Coverage News on Teva's (TEVA) Migraine Drug is a 'Clear Negative' - Wells Fargo
Tweet Send to a Friend
Wells Fargo analyst David Maris weighed in on Teva Pharma (NYSE: TEVA) after Express Scripts announced it is not going ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
